Cardiovascular toxicity

1 paper

Latest

3 in 12 months

Antioxidants & Redox Signaling9 Oct

Immune Checkpoint Inhibitor-Induced Cardiovascular Disease: The Role of Accelerated Senescence in Vascular Dysfunction

ReviewImmune response

Cellular and Molecular Biology18 Sep

Molecular and cellular crosstalk between atherosclerosis and cancer: Mechanistic insights and therapeutic opportunities

ReviewMechanisms

Frontiers in Immunology27 Aug

Molecular basis of coronary artery disease-malignancy comorbidity: inflammation, immunometabolism, thrombosis, and cardio-oncology translation

ReviewInflammation

bioRxiv1 Aug

Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Aortic Stiffening: Role of Glycation Stress

Preprint: experiments in animalsInterventions

Ecotoxicology and Environmental Safety14 Jul

Association of benzene exposure and atrial fibrillation in a national cohort: The modifying effect of genetic susceptibility

Study in peoplePopulations

Circulation19 Mar

Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association

ReviewIndustry & policy

Frontiers in Pharmacology24 Jan

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)

ReviewInterventions